Paracrine Overexpression of IGFBP-4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation

Mei Zhang, Marie Claude Faugere, Hartmut Malluche, Clifford J. Rosen, Steven D. Chernausek, Thomas Clemens

Research output: Contribution to journalArticle

Abstract

Insulin-like growth factor binding protein 4 (IGFBP-4) is abundantly expressed in bone and is generally believed to function as an inhibitor of IGF action. To investigate the function of locally produced IGFBP-4 in bone in vivo, we targeted expression of IGFBP-4 to osteoblasts using a human osteocalcin promoter to direct transgene expression. IGFBP-4 protein levels in calvaria of transgenic (OC-BP4) mice as measured by Western ligand blot were increased 25-fold over the endogenous level. Interestingly, levels of IGFBP-5 were decreased in the OC-BP4 mice, possibly because of a compensatory alteration in IGF-1 action. Morphometric measurements showed a decrease in femoral length and total bone volume in transgenic animals compared with the controls. Quantitative histomorphometry at the distal femur disclosed a striking reduction in bone turnover in the OC-BP4 mice. Osteoblast number/bone length and bone formation rate/bone surface in OC-BP4 mice were approximately one-half that seen in control mice. At birth, OC-BP4 mice were of normal size and weight but exhibited striking postnatal growth retardation. Organ allometry (mg/g body weight) analysis revealed that, whereas most organs exhibited a proportional reduction in weight, calvarial and femoral wet weights were disproportionally small (∼70% and 80% of control, respectively). In conclusion, paracrine overexpression of IGFBP-4 in the bone microenvironment markedly reduced cancellous bone formation and turnover and severely impaired overall postnatal skeletal and somatic growth. We attribute these effects to the sequestration of IGF-1 by IGFBP-4 and consequent impairment of IGF-1 action in skeletal tissue.

Original languageEnglish (US)
Pages (from-to)836-843
Number of pages8
JournalJournal of Bone and Mineral Research
Volume18
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Protein 4
Bone Remodeling
Osteoblasts
Transgenic Mice
Bone and Bones
Growth
Insulin-Like Growth Factor I
Thigh
Osteogenesis
Insulin-Like Growth Factor Binding Protein 5
Weights and Measures
Genetically Modified Animals
Osteocalcin
Transgenes
Skull
Femur
Weight Loss
Western Blotting
Body Weight
Parturition

Keywords

  • Bone histomorphometry
  • Insulin-like growth factor binding proteins
  • Insulin-like growth factor-1
  • Osteoblasts
  • Transgenic mice

ASJC Scopus subject areas

  • Surgery

Cite this

Paracrine Overexpression of IGFBP-4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation. / Zhang, Mei; Faugere, Marie Claude; Malluche, Hartmut; Rosen, Clifford J.; Chernausek, Steven D.; Clemens, Thomas.

In: Journal of Bone and Mineral Research, Vol. 18, No. 5, 01.05.2003, p. 836-843.

Research output: Contribution to journalArticle

Zhang, Mei ; Faugere, Marie Claude ; Malluche, Hartmut ; Rosen, Clifford J. ; Chernausek, Steven D. ; Clemens, Thomas. / Paracrine Overexpression of IGFBP-4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation. In: Journal of Bone and Mineral Research. 2003 ; Vol. 18, No. 5. pp. 836-843.
@article{4b5c5e3f868f408596800921a84893b3,
title = "Paracrine Overexpression of IGFBP-4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation",
abstract = "Insulin-like growth factor binding protein 4 (IGFBP-4) is abundantly expressed in bone and is generally believed to function as an inhibitor of IGF action. To investigate the function of locally produced IGFBP-4 in bone in vivo, we targeted expression of IGFBP-4 to osteoblasts using a human osteocalcin promoter to direct transgene expression. IGFBP-4 protein levels in calvaria of transgenic (OC-BP4) mice as measured by Western ligand blot were increased 25-fold over the endogenous level. Interestingly, levels of IGFBP-5 were decreased in the OC-BP4 mice, possibly because of a compensatory alteration in IGF-1 action. Morphometric measurements showed a decrease in femoral length and total bone volume in transgenic animals compared with the controls. Quantitative histomorphometry at the distal femur disclosed a striking reduction in bone turnover in the OC-BP4 mice. Osteoblast number/bone length and bone formation rate/bone surface in OC-BP4 mice were approximately one-half that seen in control mice. At birth, OC-BP4 mice were of normal size and weight but exhibited striking postnatal growth retardation. Organ allometry (mg/g body weight) analysis revealed that, whereas most organs exhibited a proportional reduction in weight, calvarial and femoral wet weights were disproportionally small (∼70{\%} and 80{\%} of control, respectively). In conclusion, paracrine overexpression of IGFBP-4 in the bone microenvironment markedly reduced cancellous bone formation and turnover and severely impaired overall postnatal skeletal and somatic growth. We attribute these effects to the sequestration of IGF-1 by IGFBP-4 and consequent impairment of IGF-1 action in skeletal tissue.",
keywords = "Bone histomorphometry, Insulin-like growth factor binding proteins, Insulin-like growth factor-1, Osteoblasts, Transgenic mice",
author = "Mei Zhang and Faugere, {Marie Claude} and Hartmut Malluche and Rosen, {Clifford J.} and Chernausek, {Steven D.} and Thomas Clemens",
year = "2003",
month = "5",
day = "1",
doi = "10.1359/jbmr.2003.18.5.836",
language = "English (US)",
volume = "18",
pages = "836--843",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Paracrine Overexpression of IGFBP-4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation

AU - Zhang, Mei

AU - Faugere, Marie Claude

AU - Malluche, Hartmut

AU - Rosen, Clifford J.

AU - Chernausek, Steven D.

AU - Clemens, Thomas

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Insulin-like growth factor binding protein 4 (IGFBP-4) is abundantly expressed in bone and is generally believed to function as an inhibitor of IGF action. To investigate the function of locally produced IGFBP-4 in bone in vivo, we targeted expression of IGFBP-4 to osteoblasts using a human osteocalcin promoter to direct transgene expression. IGFBP-4 protein levels in calvaria of transgenic (OC-BP4) mice as measured by Western ligand blot were increased 25-fold over the endogenous level. Interestingly, levels of IGFBP-5 were decreased in the OC-BP4 mice, possibly because of a compensatory alteration in IGF-1 action. Morphometric measurements showed a decrease in femoral length and total bone volume in transgenic animals compared with the controls. Quantitative histomorphometry at the distal femur disclosed a striking reduction in bone turnover in the OC-BP4 mice. Osteoblast number/bone length and bone formation rate/bone surface in OC-BP4 mice were approximately one-half that seen in control mice. At birth, OC-BP4 mice were of normal size and weight but exhibited striking postnatal growth retardation. Organ allometry (mg/g body weight) analysis revealed that, whereas most organs exhibited a proportional reduction in weight, calvarial and femoral wet weights were disproportionally small (∼70% and 80% of control, respectively). In conclusion, paracrine overexpression of IGFBP-4 in the bone microenvironment markedly reduced cancellous bone formation and turnover and severely impaired overall postnatal skeletal and somatic growth. We attribute these effects to the sequestration of IGF-1 by IGFBP-4 and consequent impairment of IGF-1 action in skeletal tissue.

AB - Insulin-like growth factor binding protein 4 (IGFBP-4) is abundantly expressed in bone and is generally believed to function as an inhibitor of IGF action. To investigate the function of locally produced IGFBP-4 in bone in vivo, we targeted expression of IGFBP-4 to osteoblasts using a human osteocalcin promoter to direct transgene expression. IGFBP-4 protein levels in calvaria of transgenic (OC-BP4) mice as measured by Western ligand blot were increased 25-fold over the endogenous level. Interestingly, levels of IGFBP-5 were decreased in the OC-BP4 mice, possibly because of a compensatory alteration in IGF-1 action. Morphometric measurements showed a decrease in femoral length and total bone volume in transgenic animals compared with the controls. Quantitative histomorphometry at the distal femur disclosed a striking reduction in bone turnover in the OC-BP4 mice. Osteoblast number/bone length and bone formation rate/bone surface in OC-BP4 mice were approximately one-half that seen in control mice. At birth, OC-BP4 mice were of normal size and weight but exhibited striking postnatal growth retardation. Organ allometry (mg/g body weight) analysis revealed that, whereas most organs exhibited a proportional reduction in weight, calvarial and femoral wet weights were disproportionally small (∼70% and 80% of control, respectively). In conclusion, paracrine overexpression of IGFBP-4 in the bone microenvironment markedly reduced cancellous bone formation and turnover and severely impaired overall postnatal skeletal and somatic growth. We attribute these effects to the sequestration of IGF-1 by IGFBP-4 and consequent impairment of IGF-1 action in skeletal tissue.

KW - Bone histomorphometry

KW - Insulin-like growth factor binding proteins

KW - Insulin-like growth factor-1

KW - Osteoblasts

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0142027567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142027567&partnerID=8YFLogxK

U2 - 10.1359/jbmr.2003.18.5.836

DO - 10.1359/jbmr.2003.18.5.836

M3 - Article

VL - 18

SP - 836

EP - 843

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 5

ER -